Realizing the Promise of Gene Therapy: Current Challenges and Future Opportunities

11:05 AM - 11:50 AM (EDT), Wednesday, June 16, 2021
Search General Info
Search Education
Search Partnering Companies

Gene therapies are transforming patients’ lives in ways unimaginable 20 years ago—and recent scientific advances with both clinical stage and commercial gene therapies have made some previously untreatable genetic diseases now treatable. With these advances come new approaches to developing and delivering genetic medicines—and new challenges. Gain insights and perspectives from stakeholders with experience tackling these challenges while bringing new types of treatments to patients. Find out what progress has been made since BIO 2020 and what opportunities are on the horizon for this exciting field. 

Moderator
photo
Senior Vice President, Global Gene Therapy Business, Rare Disease
Pfizer, Inc.
Speakers
photo
President, Therapeutics
Asklepios BioPharmaceutical, Inc. (AskBio)
photo
President and Chief Executive Officer
Audentes Therapeutics, an Astellas company
photo
Managing Director
Morgan Stanley
photo
Director, Centers for Biologics Evaluation & Research
US Food and Drug Administration
photo
CEO
Cure Duchenne